NHS trusts challenge Palantir AI benefits claims

A recent investigation reveals many NHS hospital trusts are not fully utilising Palantir’s medical data platform. Dozens of trusts publicly lauded for "realising benefits" confirm the system remains largely inactive or unused.

The Health Secretary faces escalating pressure from MPs to terminate the controversial £330m US tech firm’s contract. Palantir vehemently defends its flagship system, dismissing critics as suffering from "Palantir Derangement Syndrome."

NHS England has previously faced intense scrutiny over its data claims justifying the platform’s efficacy. A regulatory watchdog now plans to investigate fresh assertions regarding trusts "realising benefits" from the technology.

Over a hundred freedom of information requests exposed the stark discrepancy between official statements and reality. Influential parliamentary committees are now pressuring ministers to activate a break clause and seek alternative suppliers.

NHS England maintains that numerous trusts derive varied advantages, including crucial back-office data analysis capabilities. Palantir champions its software, highlighting significant operational improvements like reduced discharge delays and increased surgeries.